Valuation (33%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.21 | N/A |
PEG Ratio (TTM) | 0.00 | N/A |
P/S Ratio (TTM) | 4.09 | N/A |
P/B Ratio (TTM) | 0.18 | N/A |
P/FCF Ratio (TTM) | -0.27 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -84.64% | N/A |
ROE (TTM) | -81.66% | N/A |
Net Profit Margin (TTM) | -1,615.79% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -5.73% | -1,181.97% | N/A |
Revenue | -25.00% | 1,010.13% | N/A |
Net Income | 1.51% | -1,909.13% | N/A |
Cash Flow | -6.49% | -2,818.34% | N/A |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 14.81 | N/A |
Quick Ratio (TTM) | 14.81 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |